The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.50
Bid: 36.00
Ask: 37.00
Change: 7.50 (25.86%)
Spread: 1.00 (2.778%)
Open: 29.00
High: 36.50
Low: 29.00
Prev. Close: 29.00
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Northamber loss widens; Ethernity contract boost

Thu, 28th Mar 2024 13:44

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Northamber PLC - London-based distributor of audio-visual and information technology equipment - Revenue in the six months to December 31 falls to GBP29.2 million from GBP33.6 million while pretax loss widens to GBP413,000 from GBP250,000. Notes broader macro-economic factors and market sentiment impacted the industry. Explains softer demand resulted in slower stock turns, leading to an increase in stock at period end of GBP10.3 million compared to GBP9.6 million. Proposes unchanged interim dividend of 0.3p. Remains cautious short term as the UK market continues to be challenging but notes industry analysts expect a recovery through 2024 in demand levels as business confidence hopefully returns.

----------

Ethernity Networks Ltd - Israel-based supplier of data processing semiconductor technology for networking appliances - Announces business update. Highlights positive engagement with a number of potential new customers, including two OEM vendors which, following an extensive evaluation of Ethernity's Universal Edge Platform have indicated an interest to adopt and launch the product to their customer base. Talks continue with these two vendors on potential contracts that could lead to significant business for Ethernity. Estimates the contracts could contribute between USD2.2 million and USD3 million to revenue in 2024, plus "significantly higher revenues in 2025 and beyond".

----------

Rurelec PLC - gas producer focused on operations in Latin America - Reports pretax profit in the six months to December 31 of GBP559,000, swinging from pretax loss of GBP2.9 million. Earnings per share total 0.09 pence compared to LPS of 0.51p. Administration expenses decline to GBP0.31 million from GBP0.48 million. Explains the board's strategy is now to seek a reverse takeover "through which to generate value for our shareholders, and to give the company access to further resource thereby allowing more time to achieve a sale of the two Siemens 701 turbines." Adds: "While we continue to hold discussions with credible potential purchasers of the turbines, these initiatives are at an early stage following the withdrawal of counterparties to our earlier discussions for reasons unconnected with Rurelec. The timing of any potential sale of the turbines remains highly uncertain owing to the limited demand and infrequent occurrence of projects into which the turbines could be injected."

----------

Sareum Holdings PLC - Reports pretax loss in the six months to December 31 widens to GBP3.3 million from GBP1.7 million. No revenue was disclosed as per the year prior. Operating expenses rise to GBP2.5 million from GBP1.7 million. Basic and diluted loss per share totals 3.6 pence compared to 2.1p. Further, raises GBP1.5 million via placing, subscription and retail offer at 10p per share. Intends to use proceeds to complete Phase 1a clinical studies on its SDC-1801 TYK2/JAK1 inhibitor and, together with the receipt of an anticipated R&D tax credit of GBP0.7 million for general working capital purposes.

----------

Team PLC - wealth, asset management and complementary financial services group - Plans to raise GBP1.1 million via GBP700,000 placing and GBP400,000 subscription at 20 pence per share. Explains funds will be used for the financing of acquisitions and deferred consideration, as well as providing cash for working capital and general corporate purposes. Notes fundraise is supported by existing and new shareholders. Further, intends to raise GBP750,000 via retail offer.

----------

First Tin PLC - London-based tin development company focused on advanced, low-capital expenditure projects in Germany and Australia - Reports pretax loss in 2023 narrows to GBP2.3 million from GBP3.2 million the year prior. Diluted loss per share totals 0.85 pence compared to 1.40p. Says 2024 is shaping up to be "another busy year" with the definitive feasibility study at the Taronga asset soon to be completed and the finalisation of the mineral resource estimate at the Tellerhauser asset in the third quarter. "Our outlook for the tin market remains bullish, and we are already seeing strong signs of tin price recovery. The demand for tin remains ever-present as tin becomes increasingly recognised as crucial to the global energy transition and digital revolution," company states.

----------

Home REIT PLC - London-based real estate company, which focuses on investing in accommodation for homeless people - Sells 63 properties for GBP6.1 million, around 1.8% of the company's portfolio by value. Notes gross proceeds from the sales are GBP0.5 million, below the draft August 2023 values. Explains the majority of the properties sold are below portfolio average lot size which may cause a greater percentage variation when comparing sale price to the August draft valuation. Since August 2023, the company has completed on the sale of 451 properties and exchanged on a further 257 properties. Sale proceeds will be used to reduce borrowings and provide working capital.

----------

React Group PLC - Birmingham, England-based cleaning, hygiene and decontamination firm - Issues trading statement ahead of Thursday's annual general meeting. Reports that revenue for the first five months of the current financial year ending September is ahead of the same period in last year. Says: "Each division has performed well and the group continues to benefit from cross selling opportunities which not only enhance our offering but also contribute to the organic growth. It is particularly pleasing to deliver revenue growth in a challenging market environment where our customers are always striving for the best in class service that we offer."

----------

Westminster Group PLC - London-based provider of security services, for sensitive places such as ports, airports and commercial buildings - Revenue in the six months to December 31 falls to GBP2.9 million from GBP3.5 million the year before, while pretax loss widens to GBP1.9 million from GBP287,000. Loss per share totals 0.58 pence compared to 0.09p. Chief Executive Peter Fowler says: "We continue to battle against probably one of the worst world economic and political backgrounds in recent times." Explains revenue fell largely due to the economic climate delaying some capital-intensive orders. Fowler adds: "We started 2024 with an order book of GBP1.1 million and recurring revenues of GBP3.7 million which provide a healthy start for the year. With DRC expected to come on stream and other potential projects in the pipeline we believe the months and year ahead will be transformative for the group."

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
5 May 2023 15:53

Sareum gets approval for phase one psoriasis studies in Australia

(Sharecast News) - Biotechnology developer Sareum Holdings announced on Friday that it has been granted approval by Australia's Therapeutic Goods Administration (TGA) to conduct phase one clinical studies on SDC-1801.

Read more
5 May 2023 11:26

Sareum receives Australian approval for psoriasis drug clinical trial

Alliance News) - Sareum Holdings PLC on Friday said its application to start a phase 1 clinical trial in Australia of its lead product, psoriasis drug SDC-1801, has been approved.

Read more
5 May 2023 11:11

AIM WINNERS & LOSERS: Aptamer says struggling to convert pipeline

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
22 Mar 2023 11:47

Sareum Holdings interim loss widens as touts psoriasis candidate drug

(Alliance News) - Sareum Holdings PLC on Wednesday reported an increased half-year loss for the six months to December 31, as it continued to work on its psorasis candidate drug SDC-1801.

Read more
17 Mar 2023 18:06

IN BRIEF: Sareum makes trial application for SDC-1801 in Australia

Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune disease and cancer - On Wednesday, says it has begun an application to perform phase one clinical studies on SDC-1801 in Australia under the clinical trial notification scheme.

Read more
15 Mar 2023 15:43

UK earnings, trading statements calendar - next 7 days

Thursday 16 March 
Capital LtdFull Year Results
Centamin PLCFull Year Results
Deliveroo PLCFull Year Results
DFS Furniture PLCHalf Year Results
Empiric Student Property PLCFull Year Results
Eurocell PLCFull Year Results
FW ThorpeHalf Year Results (TBC)
Gelion PLCHalf Year Results
Gem Diamonds LtdFull Year Results
Gym Group PLCFull Year Results
Halma PLCTrading Statement
Helios Towers PLCFull Year Results
Hostmore PLCFull Year Results
Investec PLC and LtdTrading Statement
National World PLCFull Year Results
OSB Group PLCFull Year Results
PensionBee Group PLCFull Year Results
Polymetal International PLCfull Year Results
PYX Resources LtdFull Year Results
Rentokil Initial PLCFull Year Results
Restore PLCFull Year Results
Savills PLCFull Year Results
TI Fluid Systems PLCFull Year Results
WAG Payment Solutions PLCFull Year Results
Friday 17 March 
no events scheduled 
Monday 20 March 
Jubilee Metals Group PLCHalf Year Results
Tuesday 21 March 
Alliance Pharma PLCFull Year Results
Aptitude Software Group PLCFull Year Results
Boku IncFull Year Results
Diversified Energy Co PLCFull Year Results
Ergomed PLCFull Year Results
Fintel PLCFull Year Results
Gamma Communications PLCFull Year Results
Henry Boot PLCFull Year Results
Kape Technologies PLCFull Year Results
Kingfisher PLCFull Year Results
Luceco PLCFull Year Results
MP Evans Group PLCFull Year Results
Ocado Group PLCTrading Statement
Oxford Nanopore Technologies PLCFull Year Results
Pebble Group PLCFull Year Results
Quixant PLCFull Year Results
ScS Group PLCHalf Year Results
SThree PLCTrading Statement
Staffline Group PLCFull Year Results
Tissue Regenix Group PLCFull Year Results
Trustpilot Group PLCFull Year Results
YouGov PLCHalf Year Results
Zotefoams PLCFull Year Results
Wednesday 22 March 
Anpario PLCFull Year Results
Atalaya Mining PLCFull Year Results
BioPharma Credit PLCFull Year Results
Blackbird PLCFull Year Results
Bloomsbury Publishing PLCTrading Statement
Essentra PLCFull Year Results
Fevertree Drinks PLCFull Year Results
Genel Energy PLCFull Year Results
Gresham House PLCFull Year Results
Hostelworld Group PLCFull Year Results
Judges Scientific PLCFull Year Results
Kenmare Resources PLCFull Year Results
LSL Property Services PLCFull Year Results
Mpac Group PLCFull Year Results
NAHL Group PLCFull Year Results
Pendragon PLCFull Year Results
Pharos Energy PLCFull Year Results
Sareum Holdings PLCHalf Year Results
Ten Entertainment Group PLCFull Year Results
Tribal Group PLCFull Year Results
Vistry Group PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
6 Mar 2023 16:16

Sareum looks at options as GSK division returns cancer drug candidate

(Sharecast News) - Biotechnology developer Sareum announced on Monday that GSK subsidiary Sierra Oncology has returned clinical study reports and associated documents related to 'SRA737' to Sareum's co-development partner, the CRT Pioneer Fund.

Read more
6 Mar 2023 11:19

Sareum says GSK's Sierra returns clinical study reports to CRT Pioneer

(Alliance News) - Sareum Holdings PLC on Monday said that GSK PLC subsidiary Sierra Oncology Inc has completed the return of the clinical study reports relating to SRA737 to Sarerum's co-development partner CRT Pioneer Fund LP.

Read more
16 Dec 2022 21:53

TRADING UPDATES: Dev Clever to cancel shares; Tintra raises funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
16 Dec 2022 16:55

Sareum confident despite recent setbacks

(Sharecast News) - Autoimmune and cancer-focussed biotechnology company Sareum said in an update on Friday that it remained "confident" despite some recent setbacks.

Read more
16 Dec 2022 10:44

AIM WINNERS & LOSERS: Time Finance jumps on strong first-half results

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
9 Dec 2022 15:43

UK shareholder meetings calendar - next 7 days

Monday 12 December 
Devolver Digital IncSGM re 2022 Long-Term Incentive Plan approval
Marwyn Value Investors LtdAGM
Osirium Technologies PLCGM re placing agreement with Allenby Capital
PCF Group PLCGM re proposed cancellation of trading on AIM
Tuesday 13 December 
Amedeo Air Four Plus LtdAGM
Avation PLCAGM
Blancco Technology Group PLCAGM
JD Sports Fashion PLCGM re remuneration policy
Macau Property Opportunities Fund LtdAGM
Softcat PLCAGM
Spectris PLCGM re remuneration policy
Wednesday 14 December 
Fidelity Special Values PLCAGM
Kistos PLCGM re new non-operational entity
Parsley Box Group PLCGM re proposal to become a private limited company
TP Group PLCGM re cash acquisition
Volution Group PLCAGM
Westpac Banking CorpAGM
Thursday 15 December 
Aeorema Communications PLCAGM
Argos Resources LtdAGM
Baillie Gifford Japan Trust PLCAGM
Capricorn Energy PLCGM re proposed share premium account cancellation
Chelverton Growth Trust PLCAGM
CQS Natural Resources Growth & Income PLCAGM
DX Group PLCAGM
DXS International PLCAGM
Glenveagh Properties PLCEGM
Secured Income Fund PLCGM re proposed reduction of capital
Schroder Income Growth Fund PLCAGM
Friday 16 December 
Bellway PLCAGM
Inchcape PLCGM re Derco acquisition
JPMorgan Global Growth & Income PLCGM re proposed combination with JPMorgan Elect PLC
National Australia Bank LtdAGM
Sareum Holdings PLCAGM
Thor Explorations LtdAGM
UP Global Sourcing Holdings PLCAGM
  
Copyright 2022 Alliance News Ltd. All Rights Reserved.

Read more
21 Nov 2022 12:44

IN BRIEF: Sareum salutes publication of SRA737 combination trial data

Sareum Holdings PLC - Cambridge, England-based biotechnology company focused on developing kinase inhibitors for autoimmune disease & cancer - Says it is pleased by the publication of data from the Phase 1/2 trial of SRA737 as a combination treatment for advanced cancers in the medical journal, Clinical Cancer Research.

Read more
24 Oct 2022 10:28

IN BRIEF: Sareum widens annual loss; considers future of SRA737

Sareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - In the year ended June 30, pretax loss widens to GBP2.6 million from GBP1.7 million a year before. No revenue is recorded in either year, but in the previous year it brought in GBP171,000 in other operating income, with none recorded for financial 2022. Says it will discuss the future of SRA737 with partner Cancer Research Technology Pioneer Fund. Earlier this month, GSK PLC subsidiary Sierra Oncology Inc said it intends to return the rights for the SRA737 cancer treatment to CPF.

Read more
12 Oct 2022 10:47

Sareum plunges as GSK subsidiary Sierra returns rights for SRA737

(Alliance News) - Sareum Holdings PLC on Wednesday after Sierra Oncology Inc, a subsidiary of GSK PLC, said it intends to return the rights for SRA737 to the CRT Pioneer Fund LP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.